Kevin Kumar Vijayakumar

Kevin Kumar Vijayakumar

Auto-generated profile, based on publicly available information

Kevin Kumar Vijayakumar

Department of Molecular Microbiology, School of Biotechnology, Madurai Kamaraj University, Madurai, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2022 in Heliyon
Verified
Journal Article
Open access
SPSureshbabu Ram Kumar Pandian
Sureshbabu Ram Kumar Pandian
KVKevin Kumar Vijayakumar
Kevin Kumar Vijayakumar
MSMurugesan Sankaranarayanan
Murugesan Sankaranarayanan
SKSelvaraj Kunjiappan
Selvaraj Kunjiappan
The function of the brain can be affected by various factors that include infection, tumor, and stroke. The major disorders reported with altered brain function are Alzheimer's disease (AD), Parkinson's disease (PD), dementia, brain cancer, seizures, mental disorders, and other movement disorders. The major barrier in treating CNS disease is the blood-brain barrier (BBB), which protects the brain from toxic molecules, and the cerebrospinal fluid (CSF) barrier, which separates blood from CSF. Brain endothelial cells and perivascular elements provide an integrated cellular barrier, the BBB, which hamper the invasion of molecules from the blood to the brain. Even though many drugs are available to treat neurological disorders, it fails to reach the desired site with the required concentration. In this purview, liposomes can carry required concentrations of molecules intracellular by diverse routes such as carrier-mediated transport and receptor-mediated transcytosis. Surface modification of liposomes enables them to deliver drugs to various brain cells, including neurons, astrocytes, oligodendrocytes, and microglia. The research studies supported the role of liposomes in delivering drugs across BBB and in reducing the pathogenesis of AD and PD. The liposomes were surface-functionalized with various molecules to reach the cells intricated with the AD or PD pathogenesis. The targeted and sustained delivery of drugs by liposomes is disturbed due to the antibody formation, renal clearance, accelerated blood clearance, and complement activation–related pseudoallergy (CARPA). Hence, this review will focus on the characteristics, surface functionalization, drug loading, and biodistribution of liposomes respective to AD and PD. In addition, the alternative strategies to overcome immunogenicity are discussed briefly.

7 July 2022 in Clinical and Experimental Medicine
Verified
Journal Article
Closed access
PDF file
SPSureshbabu Ram Kumar Pandian
Sureshbabu Ram Kumar Pandian
KVKevin Kumar Vijayakumar
Kevin Kumar Vijayakumar
SKSelvaraj Kunjiappan
Selvaraj Kunjiappan
EBEwa Babkiewicz
Ewa Babkiewicz
PMPiotr Maszczyk
Piotr Maszczyk

30 September 2021 in Biomedical and Pharmacology Journal
Verified
Journal Article
Open access
PRPushparaju Ramasamy
Pushparaju Ramasamy
VSVignesh Sounderrajan
Vignesh Sounderrajan
KVKevin Kumar Vijayakumar
Kevin Kumar Vijayakumar
HSHarshavardhan Shakila
Harshavardhan Shakila
Globally, rising drug-resistant tuberculosis is a significant public health concern. Prompt diagnosis of tuberculosis and detection of drug-resistant TB within a clinically appropriate timeframe is important for the effective management of the disease. Imaging approaches Chest X-rays, CT, MRI, nuclear medicine technique as PET/CT are non-specific, plays an important role in the diagnosis and assessment of TB, but PET/CT sometimes results in false-positive or negative due to benign lesions.Currently using the point of care molecular modalities, Gene Xpert MTB/RIF and line probe assays focused only on resistance-conferring mutations in specific target hotspot regions, but did not identify novel mutations, outside mutations and they may miss some locally prevalent rifampicin-conferring mutations, and not provided a large number of antibiotics/antibiotic groups that are used for DRTB treatment.Recently revolutionized high throughput next generation sequencing (NGS) technologies are offering new prospects for molecular diagnosis, for example, infectious disease pathogens like tuberculosis, influenza, and most recently SARS-CoV-2. NGS is an essential resource for the tuberculosis communityeither target, WGS, or NGS; a rapid method that offers a complete spectrum of Mycobacterium tuberculosis resistance mutations, strain typing for transmission surveillance, unlike traditional molecular or phenotypic DST. It shall be helpful for early regimen design and TB management before mutations emerge and therefore, we believe that the worldwide TB infection will be eliminated by the use of NGS.

24 August 2024 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
KVKevin Kumar Vijayakumar
Kevin Kumar Vijayakumar
DMDevaprakash Manoharan
Devaprakash Manoharan
RSRajasekaran Subbarayan
Rajasekaran Subbarayan
Rupendra SHRESTHARupendra SHRESTHA
Rupendra SHRESTHA
HSHarshavardhan Shakila
Harshavardhan Shakila

1 January 2021 in SSRN Electronic Journal
Verified
Preprint
Open access
PDF file
SPSureshbabu Ram Kumar Pandian
Sureshbabu Ram Kumar Pandian
KVKevin Kumar Vijayakumar
Kevin Kumar Vijayakumar
MSMurugesan Sankaranarayanan
Murugesan Sankaranarayanan
SKSelvaraj Kunjiappan
Selvaraj Kunjiappan
The function of the brain can be affected by various factors that include infection, tumor and stroke. The major disorders reported with altered brain function are Alzheimer’s disease (AD), Parkinson’s disease (PD), Dementias, brain cancer, seizures, mental disorders and other movement disorders. The major barrier in the treatment of CNS disease is the blood-brain barrier (BBB), which protects the brain from toxic molecules and the cerebrospinal fluid (CSF) barrier, which separates blood from CSF. Brain endothelial cells and perivascular elements provide an integrated cellular barrier, the BBB which hamper the invasion of molecules from the blood to the brain. Though many delivery strategies such as neurosurgical, pharmacological and physiological approaches have been developed for brain delivery, their disadvantages hamper treatment success. The previously reported brain targeted delivery platforms were targeted brain cells through transferrin receptors (TfRs). The brain capillary endothelial cells express TfR on its surface. Conversely, the same receptor can be found on immature erythroid cells, placental tissue, rapidly dividing normal and malignant cells. Liposomes coupled with transferrin (Tf) ligands have proven to cross the BBB and deliver therapeutic agents into brain parenchyma. Due to the systemic preparation methods, easy manipulative physiochemical properties and the ability to penetrate BBB, liposomes are widely studied nanomaterials for brain targeted delivery. Liposomes have been proved for the delivery of biomolecules and drugs to various brain-related disorders. Hence, this review will focus on the characteristics, surface functionalization, drug loading and bio-distribution of liposomes with respective to brain diseases and disorders.